ArticleDiagnostics (Basel, Switzerland)2023

Determining HER2 Status by Artificial Intelligence: An Investigation of Primary, Metastatic, and HER2 Low Breast Tumors.

Christiane Palm et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.